Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Formulation difficulties for Manhattan's topical PTH (1-34)

May 9, 2006

Approvable letter for CIP-Isotretinoin

May 5, 2006

Phase II study of NPI-32101 completes enrollment

May 4, 2006

Chronogen cleared to begin phase I/II study of CHGN-111 in Canada

May 2, 2006

Enrollment completed in confirmatory study of OrCel in venous leg ulcers

April 28, 2006

Isotechnika signs option agreement for topical delivery of ISA-247

April 28, 2006

New androgen receptor antagonists emerge from Pfizer R&D

April 26, 2006

Pilot study of MM-093 in psoriasis completes enrollment

April 24, 2006

Positive interim phase II results for CUV-1647 in polymorphous light eruption

April 20, 2006

Taclonex now available in U.S.

April 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...